Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Was hoping a slight Increase today but Nothing
View:
Post by azzymaa on Jun 27, 2022 11:50am

Was hoping a slight Increase today but Nothing

Why is Promis so content on listing on the Nasdaq when they have no real news to portray? The SP is unchanged and after the RS the SP will surely tank. How will they maintain a 4.00 US minimum for the next 4-6 weeks? Feel sorry for the long term holders and how they will lose half of their holdings. Very bad management and a only the insiders will prosper. Pathetic company.
Comment by bball67 on Jun 27, 2022 12:37pm
AZ, it is not a pathetic company. Iam along term holder and I will not lose half of my holdings. They have the GOOD's and it appears that no one else does. They have a computational AI model that no one else has. The Nasdaq listing is coming very soon. The naysayers are wrong, this will give us so much more attention and coverage. There is positive news coming. StayTuned
Comment by Gbathat on Jun 27, 2022 8:51pm
Once they're on NASDAQ, they can attract institutional investment. That will require good news in parallel. Everything seems to be moving forward. I share your optimism through Phase I.  After that point, it will depend on results, of course.  Getting to Phase I will be a nice time for shareholders who get in at the current basement prices. Hopefully the pps rises significantly ...more  
Comment by FarmerBetty on Jun 28, 2022 4:53am
Eugene and Elliottt, confirm for long term investors after today. Congratulations sums it up !!
Comment by G1945V on Jun 28, 2022 8:01am
?
Comment by M101 on Jun 28, 2022 12:13pm
Yes, that and the core hypothesis which made the model necessary.  If the hypothesis proves out then I believe the competition will quickly build on thier own current AI enhanced drug optimization programs to achieve the same functionality as the Promis platform, but meanwhile they remain skeptics as we are about their approaches.  So while it's the hypothesis that needs to be sold ...more